Glenmark Pharmaceuticals Announces Encouraging Phase 1 Results Supporting Biosimilarity …

MAHWAH, N.J. and LA CHAUX-DE-FONDS, Switzerland, July 25, 2018 /PRNewswire/ — Glenmark Pharmaceuticals, a global pharmaceutical … … (continue)

See more: